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ABSTRACT
Background: There is consensus that dementia is the most burdensome disease for modern societies. Few
cost-of-illness studies examined the complexity of Alzheimer’s disease (AD) burden, considering at the same
time health and social care, cash allowances, informal care, and out-of-pocket expenditure by families.
Methods: This is a comprehensive cost-of-illness study based on the baseline data from a randomized
controlled trial (UP-TECH) enrolling 438 patients with moderate AD and their primary caregiver living
in the community.
Results: The societal burden of AD, composed of public, patient, and informal care costs, was about
€20,000/yr. Out of this, the cost borne by the public sector was €4,534/yr. The main driver of public cost was
the national cash-for-care allowance (€2,324/yr), followed by drug prescriptions (€1,402/yr). Out-of-pocket
expenditure predominantly concerned the cost of private care workers. The value of informal care peaked at
€13,590/yr. Socioeconomic factors do not influence AD public cost, but do affect the level of out-of-pocket
expenditure.
Conclusion: The burden of AD reflects the structure of Italian welfare. The families predominantly manage
AD patients. The public expenditure is mostly for drugs and cash-for-care benefits. From a State perspective
in the short term, the advantage of these care arrangements is clear, compared to the cost of residential care.
However, if caregivers are not adequately supported, savings may be soon offset by higher risk of caregiver
morbidity and mortality produced by high burden and stress. The study has been registered on the website
www.clinicaltrials.org (Trial Registration number: NCT01700556).
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Introduction
Dementia is becoming one of the main causes
of disability in developed countries (WHO and
ADI, 2012). In 2010, it has been estimated that
worldwide, about 35.6 million people 65 years
and older had dementia. This number is expected
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to nearly triple in the next 40 years (Thies and
Bleiler, 2011), as the prevalence and incidence
of dementia increase exponentially with age in
older subjects (Jorm and Jolley, 1998; Ferri et al.,
2005). There is wide consensus that dementia is
one of the most burdensome diseases for welfare
systems, but establishing the costs incurred by
this illness is a complex process (Costa et al.,
2012).
Previous cost-of-illness studies have used a wide
array of methods in an attempt to encompass cost
elements, but this has led to heterogeneous findings
(Schneider et al., 1999; Prince, 2004; Jonsson and
Wimo, 2009; Hurd et al., 2013; Leicht et al., 2013).
In Europe, healthcare cost estimates of Alzheimer’s
disease (AD) patients ranged from €6,435 (in
France) to €64,426 per patient per year (in the
United Kingdom), with a clear trend of increased
costs with AD severity (Jonsson and Wimo, 2009).
Informal care may account for up to 81% of the
total cost for care (Boada et al., 1999). The unpaid
time of caregivers ranged from $5,655 (mild AD)
to $3,506 (severe AD) for supervising their family
members and from $9,451 (mild AD) to $36,794
(severe AD) for direct care provision (Hux et al.,
1998).
It is known that AD cost is highly dependent
on the setting of care (community vs. residential
vs. hospital). Moreover, it has been estimated that
delaying a patient’s institutionalization can save
US$1,863 per month (Leon et al., 1998). These
findings reinforce the importance of studies to
inform cost-effective strategies aimed at avoiding
institutionalization of AD patients.
Two previous cost-of-illness studies have been
carried out in Italy (Cavallo and Fattore,
1997; Trabucchi, 1999), however, neither study
comprehensively evaluated all cost categories (e.g.,
costs of medical care, cash-for-care allowances, and
families’ out-of-pocket expenditure), nor included
data on AD severity. Furthermore, these studies did
not investigate patient and caregiver correlates of
cost.
The UP-TECH study is a multicenter,
randomized controlled clinical trial in Italy, that
enrolled 438 AD patient–caregiver dyads into three
arms. This clinical trial is investigating whether
innovative interventions, such as case management
and new technologies can improve the cost-
effectiveness of care processes for older people with
AD (Chiatti et al., 2015). The baseline assessment
performed on the enrolled patients included an in-
depth evaluation of the use of care resources, which
allowed a detailed cost-of-illness study. The results
can address important gaps in the economic analysis
of AD in Italy and represents a valuable opportunity
to inform policy.
Methods
The UP-TECH study was extensively described
elsewhere (Chiatti et al., 2013b). Briefly, lists of
AD patients were obtained from the Alzheimer’s
Evaluation Units (AEUs) from five health districts
of the Marche Region (Pesaro, Ancona, Macerata,
Fermo, San Benedetto del Tronto). Eligible
subjects were patients with a diagnosis of AD
according to the NIA-AA 2011 criteria (Albert
et al., 2011; McKhann et al., 2011), with a Mini-
Mental State Examination (MMSE) (Folstein et al.,
1975) score between 10 and 20, corresponding
to moderate stage AD, and assisted at home
by at least one family caregiver (although not
necessarily living with the caregiver herself/himself).
We included only patients with moderate AD as we
hypothesized that the impact of the interventions
tested could be more evident and cost-effective in
this subpopulation (e.g. caregiver burden was not
too high at enrollment). An invitation letter was sent
to 653 patient-family caregiver dyads retrieved from
the AEU lists who met the eligibility criteria, asking
them to participate in the research study: at the end
of the recruitment, 438 dyads were enrolled in the
project, resulting in a response rate of approximately
67% (more methodological details are described in
the protocol and the recruitment papers (Chiatti
et al., 2013b; 2015)). Data have been collected
between January 2013 and July 2013. All 438 dyads
completed baseline assessment and were included
in the present analysis.
The UP-TECH database was integrated through
record linkage with the data on hospitalizations
from the Regional administrative register of hospital
discharges. The study was submitted to the
Regional Ethics Committee, which consented to the
study being carried out.
Study variables
After obtaining a written informed consent, a
trained nurse administered a structured question-
naire, which was a modified version of the InterRAI
Contact Assessment (interRAI CA, Ann Arbor, MI,
USA) (Hirdes et al., 2010). Instrumental activities
of daily living (IADL)-performance (Barberger-
Gateau et al., 1992) and activities of daily living
(ADL)-hierarchy scales (Morris et al., 1999) were
assessed to estimate the level of cognitive and
physical performance of the patients. The IADL
Involvement Scale, which is based on a sum
of seven IADL-related items, produces a scale
that ranges from 0 to 48, with higher scores
indicating greater difficulty. ADL dependency
was summarized using the ADL Hierarchy Scale
which ranges from 0 (no impairment) to 6 (total
dependence). The caregiver’s burden was evaluated
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by administering the Caregiver Burden Inventory
(CBI) scale, developed by Novak and Guest (1989)
and validated in Italy (Marvardi et al., 2005).
The CBI is a multidimensional questionnaire
composed of five subscales: time-dependence
burden, developmental burden, physical burden,
social burden, and emotional burden. Overall, it
includes a set of 24 items evaluated using a five-
point Likert scale ranging from 0 (not at all) to
4 (very much), which are summed. (Scores can
vary from 0 to 96, with higher scores indicating
greater caregiver distress). Behavioral disturbances
of patients were appraised by asking caregivers if
the patient displayed, in the last three days, one or
more of the following symptoms: verbal or physical
aggression, socially inappropriate behavior, socially
inappropriate sexual behavior, and/or wandering.
We used caregivers’ educational attainment
and occupation as proxies of dyad socioeconomic
status (SES) (Huisman et al., 2003). Educational
level was categorized according to the years of
formal education completed: no title—primary
school (up to 5 years); intermediate (6–8 years);
high (9–14 years); university degree or higher
(>15 years). Caregivers were grouped into social
classes using present occupation, or their last job
before retirement (De Lillo and Schizzerotto, 1985;
Cardano et al., 2004).
Cost items
Data regarding the use of resources in the six
months prior to the first interview (July 2012–
December 2012) were gathered by the trained
nurses, using an ad hoc developed Resource
Use Questionnaire. The following categories of
resources were collected: (1) AD-related drugs;
(2) other drugs; (3) hospitalizations; (3) visits to
the Emergency Department (ED); (4) outpatient
visits/exams; (5) social and health interventions
provided in the community; (6) care provided
by private care workers; (7) hours of informal
care provided by the primary and other informal
caregivers. In addition, we assessed whether the
patient was granted the so-called “indennità di
accompagnamento,” the care allowance, provided
by the Italian Institute for Pensions (INPS) to
the people who have ADL and IADL limitations,
and need 24-hour assistance. The explicit aim
of the “indennità,” is to provide the patients
with supplementary money, in order to fund the
purchase of additional care services.
Cost perspectives and costing activity
A detailed description of cost categories by
perspective is reported in Table 1. The analysis uses
three different cost perspectives, and distinguishes
among the costs attributable to the public sector
(the National Health Service, the Municipalities,
and the State), to private families (i.e. out-of-pocket
expenditures) and to society as a whole. Each cost
item was assigned to the appropriate perspective,
and classified either as “public” or “private.” The
societal perspective includes both public and private
costs and additionally considers the cost of informal
care. Cost data were retrieved from official sources
when available. In lieu of official sources, the best
available data from national and local surveys were
used.
Informal caregiving was valuated using a
“replacement cost approach” (McDaid, 2001), i.e.
estimating the cost of replacing informal caregivers’
input with professional assistance. In order to be
more conservative in the final estimates (especially
as we were not able to distinguish between the hours
of supervision and direct care provision, since many
families reported 24-hour a day care patterns), we
valued the cost of informal caregivers as half of the
cost of private care workers, following the approach
used by Björkgren et al. (2000) and Poss et al.
(2008).
We used a specific assumption to deal with the
risk of double-counting the resource consumption
when the dyad declared, at the same time, that they
received the care allowance and declared out-of-
pocket expenditure. As the legal rationale of the
“indennità” is to fund out-of-pocket care-related
expenditure of families, we subtracted its value from
the total out-of-pocket expenditure for all those
patients receiving the allowance. When the value
of the “indennità” was higher than out-of-pocket
expenditure (thus hinting that the family uses part
of it for other purposes), we replaced negative values
with null quantities.
Statistical analyses
Analyses of socio-demographic characteristics of
the sample, level of patients’ disease severity,
social/educational status, resource consumption,
family relationship between patient and caregiver,
and caregiving burden were purely descriptive.
Regarding the cost analyses, two different
approaches were adopted. First, univariate (non-
parametric) analyses were performed to compare
annual costs, by perspective and patients’ age. In
this case, a bootstrap method was used to estimate
the confidence intervals of each cost item. Second,
a Generalized Linear Model (GLM) was used to
study the relation between costs and independent
variables (Schwarzkopf et al., 2012; Lindholm et al.,
2013). Model validation was carried out using the
following tests: χ2 for the family chosen; Pearson
correlation, Pregibon link, modified Hosmer, and
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Table 1. Cost categories, by perspective, included in the study
TYPE OF COST SOURCE COST PER UNIT
............................................................................................................................................................................................................................................................................................................................
Public cost
Drugs National Formulary of Drugs (v.2013/06/24) n.a.
Out-patient care National tariffs list n.a.
Emergency Department Mean cost retrieved from a national survey €242/ED visit
Hospitalization DRG tariff in the Marche Region n.a.
Community care
GP home visits GP regional contract €18.9/visit
Home healthcare Labor cost from national contract – NHS €24/h
Home help Labor cost from national contract – cooperatives €18/h
AD daycare centers Mean cost retrieved from a regional survey €30/d
Care allowance Value set by national laws €499.27/mo
Out-of-pocket expenditure
Drugs not reimbursed National Formulary of Drugs (v.2013/06/24) n.a.
Out-patient care National tariffs list n.a.
AD day care center copayment Regional survey €30/d
Private care workers Estimation of care staff cost €7.5/h
Informal care
Informal caregivers Valued as half of the cost of private care workers €3.75/h
n.a. = not applicable; AD = Alzheimer’s disease; DRG = diagnosis related group; ED = Emergency Department; GP = general
practitioner; NHS = National Health Service.
Lemeshow for link function utilized. These tests
suggested not to use the out-of-pocket expenditure
as a dependent variable, given its excessively
skewed distribution. Therefore, we chose to use
the sum of public and private costs as a proxy
variable to investigate the patterns of out-of-pocket
expenditure in the sample.
Results
General characteristics of AD patient–caregiver
dyads included in the analysis are reported in
Table 2. Patients were more frequently women,
with a mean age of 81.5 years. Their ADL-
hierarchy scale score was 1.5 out of 6, while their
IADL performance indicated greater impairment,
reaching 35.1 out of 48 on the IADL scale.
Caregivers too, were mostly women (66.2%),
usually children of the patients (55.7%) or
a spouse/partner (30.8%). Only 8.2% of the
caregivers had a university or higher degree, 36.7%
completed high school, whereas the majority only
finished intermediate school (24.9%) or primary
school/no title (30.1%). The level of caregiving
burden, measured using the CBI, reached an
average of 27.6 points (±16.8).
Prevalence of service use by AD patients
is reported in Figure 1. As a consequence of
the inclusion criteria, all patients relied on
family caregiving. Ninety-one percent of the
patients used AD-related drugs, composed of
antidementia compounds, prescribed by the AEUs,
antidepressants, antipsychotics, anxiolytics, and
hypnotics/sedatives, and 81% of them used other
drugs. Fifty-five percent of the patients reported
outpatient visits and exams in the six months
prior to the interview, and 29% were assisted
by a private care worker. Hospitalizations were
somewhat frequent in the sample (7%), as were
visits to the Emergency Department (12%).
The estimated societal burden of AD patients
was about €20,000/yr (Table 3). Out of this, the
cost borne by the public sector was €4,534/yr. This
value included the cost for direct care services
– provided by the NHS and the Municipalities
– plus the value of the cash allowances granted
by the Italian National Institute of Pensions
(INPS). The latter was indeed the largest driver
of public cost: 39% of patients received the grant
for a total yearly mean cost of €2,324. The
other significant driver of public expenditure was
prescription drugs for AD and co-morbid diseases,
which amounted to €1,402/yr, or almost 1/3 of total
public spend. Antidementia drugs were used by
approximately 51% of patients, which accounted
for the majority of AD drug costs (84%) (see
Table S1, available as supplementary material
attached to the electronic version of this paper at
www.journals.cambridge.org/jid_IPG). The most
frequently used drugs for co-morbid diseases
were cardiovascular drugs (40.1%; 31.1% cost
composition), drugs for the alimentary tract and
metabolism (19.7%; 18.2% cost composition),
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Table 2. Characteristics of the dyads patient/caregiver in the ﬁnal sample (n = 438)
N OR MEAN (% OR ±SE)
............................................................................................................................................................................................................................................................................................................................
Patients 438
Gender (female) 272 (62.1%)
Age (years) 81.5 (±5.7)
MMSE 16 (±3.0)
IADL 35.1 (±13.4)
ADL 1.5 (±1.6)
Behavioral disturbance 116 (26.5%)
Caregivers 438
Gender 290 (66.2%)
Age 61.4 (±13.0)
Relationship
Spouse/partner 135 (30.8%)
Son/daughter 244 (55.7%)
Other relative 59 (13.5%)
Educational level
No title/primary school 132 (30.1%)
Intermediate school 109 (24.9%)
High school 161 (36.7%)
University degree or higher 36 (8.2%)
Social class
Not attributed 35 (8.1%)
Lower 117 (26.8%)
Middle 79 (18.0%)
Middle-upper 145 (33.1%)
Upper 54 (12.3%)
Caregiver burden inventory 27.6 (±16.8)
Hours of informal care provided (per week)
Primary caregiver 50.2 (±50.3)
Other caregivers 20.2 (±31.3)
ADL = activities of daily living; IADL = instrumental activities of daily living; MMSE = Mini-Mental State Examination; SE = standard
error of the mean.
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Figure 1. Frequency of resource use (n= 438)
AD (Alzheimer’s Disease), ED (Emergency Department).
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Table 3. AD-related costs, by type of cost and perspective (n = 438)
P E R S P E C T I V E/T Y P E
OF COST
6-M O N T H M E A N
COST (€ ) [95% CI]
E S T I M A T E D
Y E A R L Y CO S T
(€)
% OF
SOCIETAL
BURDEN
............................................................................................................................................................................................................................................................................................................................
Public cost 2,267 [2,041.2–2,492.8] 4,534 22.5
Alzheimer’s drugs 446 [412.7–478.9] 892 4.4
Other drugs 255 [160.5–349.4] 510 2.5
Exams/visits 20 [15.8–23.8] 40 0.2
Health and social
interventions
30 [19.3–39.8] 60 0.3
Emergency
Department
31 [22.6–40.4] 62 0.3
Hospitalizations 323 [167.6–477.9] 646 3.2
State care allowances 1,162 [1,030.0–1,295.3] 2,324 11.5
Patient cost 1,487 [1,486.6–1,742.3] 2,974 n.a.
Alzheimer’s drugs 12 [7.1–17.1] 24 n.a.
Other drugs 24 [12.6–34.5] 48 n.a.
Exams/visits 1 [0.4–1.1] 2 n.a.
Health and social
interventions
7 [4.0–9.2] 14 n.a.
Private assistance 1,444 [1,185.6–1,701.6] 2,888 n.a.
Patient cost subtracting
the allowancea
1,001 [795.7–1,207.2] 2,002 14.3
Informal care 6,795 [6,241.5–7,348.7] 13,590 67.5
(Main) caregiver 4,843 [4,379.8–5,306.2] 9,686 48.1
Other caregivers 1,952 [1,674.4–2,229.9] 3,904 19.4
Societal costb 10,064 [9,437.4–10,689.7] 20,128 100.0
AD = Alzheimer’s disease; CI = confidence interval; € = Euro.
aSee the methodological section for details on how the value is computed.
bSocietal cost includes: public cost, patient cost without allowance, and informal care cost.
and blood and blood-forming organ medications
(17.2%; 25.3% cost composition) (see Table
S2, available as supplementary material attached
to the electronic version of this paper at
www.journals.cambridge.org/jid_IPG).
Out-of-pocket expenditure predominantly con-
cerned the cost of hiring private care workers, while
the cost for privately purchased drugs was rather
limited (€24 and €48 for Alzheimer and other drugs,
respectively).
The largest share of societal burden, however,
comprised informal care. Even by valuing the
hours of care, provided by family caregivers, at
half the rate of the lowest skilled labor (private
care workers), the value of the societal burden
peaked at €13,590/yr (67.5% of total costs).
Forty-seven percent of caregivers (primary +
secondary) expended 41–168 h/wk assisting the
patient (see Figure S1, available as supplementary
material attached to the electronic version of this
paper at www.journals.cambridge.org/jid_IPG).
Ten percent of households spent >168 h/wk caring
for the AD patient, while 33% and 10% of family
members spent, respectively, 15–40 and 0–14 h/wk
looking after the Alzheimer’s patient. The family
members who spent the majority of time on
caregiving were spouses/partners (70 h/wk) followed
by grandchildren (44 h/wk) and children-in-law
(30 h/wk) (see Figure S2, available as supplement-
ary material attached to the electronic version of this
paper at www.journals.cambridge.org/jid_IPG).
Predictors of total costs are shown in Table 4.
IADL dependency was the only significant predictor
of public cost. IADL impairment also influenced
the consumption of resources when considering the
total public and private expenditure. In addition,
the sum of public and private expenditure correlated
with higher level of education. Again, impaired
IADL status was associated with increased societal
cost, whereas cognitive impairment was negatively
correlated. Among the characteristics of caregivers,
only CBI score was associated with increased
societal expenditure.
Discussion
Our study sheds light on the overall burden of AD
in a population of patients at a moderate stage of
the disease. By examining the costs using three
different perspectives, the expenditure of the public
sector (the State, the Municipalities and the NHS)
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Table 4. Predictors of total costs (all perspectives; n = 438)
MODEL COEFF. STANDARD ERROR p
............................................................................................................................................................................................................................................................................................................................
Model 1. Predictors of public cost
• IADL 0.0291 0.001 0.001
Model 2. Predictors of public + private cost
• IADL 0.0375 0.006 0.001
• Educational level: high school versus no title/primary level 0.6188 0.261 0.018
Model 3. Predictors of societal cost
• MMSE − 0.0302 0.010 0.002
• IADL 0.0247 0.003 0.001
• CBI 0.006 0.002 0.005
All models are adjusted for characteristics of patients (age, gender, ADL, IADL, and MMSE) and caregivers (age, gender, CBI, statuses,
and education level).
ADL = activities of daily living; CBI = Caregiver Burden Inventory; IADL = instrumental activities of daily living; MMSE = Mini-Mental
State Examination; Coeff. = correlation coefficient; p = probability; Standard Error = standard error of the mean.
was relatively low compared to the overall societal
burden. The preference of the Italian Welfare State
for cash-for-care allowances, instead of direct care
services, was clearly reflected by our results (Shutes
and Chiatti, 2012). The cost for care allowances
overwhelmed the cost for direct care provision.
In many cases the total cost of the care subsidy
exceeded that of out-of-pocket expenditure by
recipients, suggesting that a substantial part of the
allowance was spent in other ways. This reinforces
the widespread idea, that in Italy, this care subsidy
is a form of compensation for carers’ work and
complements the income of Italian families. The
implications for social policy are indeed relevant and
suggest the need for new regulations to increase the
accountability of how the care allowance is used.
Prescription drug expenditure accounted for the
largest share of the remaining public cost, while
the amount of public spending for care services in
the community was negligible. Another emerging
characteristic was the relevance of the support
provided by private care workers (Chiatti et al.,
2013a), which represented the major driver of out-
of-pocket expenditure.
Two previous cost-of-illness studies have been
carried out in Italy (Cavallo and Fattore, 1997;
Trabucchi, 1999), however, neither study assessed
the costs of medical care. This reflected the
structure of dementia care in the country, which
traditionally falls outside of the NHS. Moreover,
neither study included information on disease
severity, nor were they based on a large sample of
AD patients assessed by specifically trained research
nurses. Cavallo and Fattore’s study was based on a
postal survey (Cavallo and Fattore, 1997), while the
CoDem study (Trabucchi, 1999) included only 103
AD patients. In these two investigations, the level of
informal care ranged from 61.6 h/wk (for personal
support only) to 124.6 h/wk for patients with severe
dementia (a Clinical Dementia Rating score of 3).
In our study, the number of hours of informal care
provided by the primary caregiver (supervision +
direct care) peaked to a mean of 50.2 h/wk, to which
must be added an extra 20 h/wk from other informal
caregivers.
The importance of informal assistance provided
by Italian families, outside of the market, was
evident in two ways. First, the value of the social
cost peaked at €13,590/yr or 67.5% of total costs.
Second, the public expenditure was significantly less
than those same patients would incur in residential
care. In the Marche Region, where our study is
being carried out, the cost for a year spent in
institutional care, for a patient with moderate AD,
could vary from €12,045 to €14,600, in contrast
to €4,534 for public expenditure of patients living
at home, observed in our sample (Marche, 2010).
The crucial role of informal caregiving is not
limited to Italy. In a recent study carried out in
Germany, total costs for community-based caring,
after adjusting for age, gender, functional status
(ADL and IADL), and co-morbidity, were higher
than total costs for nursing home-based caring,
mainly due to the higher costs of informal care
(Konig et al., 2014). From a State perspective in
the short term, the “convenience” of these care
arrangements in the community is apparent, since
the alternative, residential care settings, is clearly
more burdensome. However, if caregivers are not
adequately supported, these savings may be soon
offset, given the high burden, stress, and often
advanced age of caregivers, which expose them to
a higher risk of morbidity and mortality (Vitaliano
et al., 2003). Already the caregivers in our sample
population were close to the threshold for anxiety
and depression (McDowell, 2006; Chiatti et al.,
2015). Studies have determined that these mood
disorders were associated with much higher public
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costs for older people living at home (Vasiliadis
et al., 2013), as well as healthcare costs for older
patients (Luppa et al., 2008).
In this study, we distinguished the share of
cost directly attributable to AD from that which
might be associated with other diseases and/or
physical dependency. In this regard, previous
evidence pointed out that potentially sizeable
savings could be achieved by the management of
co-morbidities in people with dementia (Knapp
et al., 2013). We found that a large share of the
public costs was related to disease co-morbidities
(e.g. drugs and hospitalizations), suggesting the
need to specifically target this population, for
instance, by improving prescription appropriateness
through medication reviews and/or improving the
compliance to therapy.
In the regression analysis of cost predictors,
functional impairment, rather than cognitive
impairment, more consistently predicted the use of
resources. (The only exception was the correlation
between a higher MMSE score and overall societal
burden.) This is in line with previous evidence
(Lindholm et al., 2013), suggesting that IADL
dependency is the main driver of care cost
among AD patients. We found no socioeconomic
correlates of public spending, which is consistent
with the mission of the Italian welfare system to
universally provide assistance (although the overall
level dispensed is relatively small). Conversely, the
role of caregiver education suggested the probable
association between a higher SES and a higher
expenditure for the care of the AD patients. These
findings raise the issue of equity of care, since it
reveals the additional risk of caregiving burden,
for those families with lower financial means. The
disadvantages of dyads with a lower educational
status will increase as the public support for
dementia continues to retrench as a result of the
financial crisis in the Mediterranean countries.
Caregiver social class was not significantly
correlated with AD burden in the multivariate
analysis, once educational attainment was inserted
into the models. This suggests that caregiver
educational level has a stronger impact in
determining the care arrangements of the patients,
which may also be connected to the fact that, due
to a limitation of the study questionnaire, we could
not measure family social class, but only individuals’
social class (Erikson, 1984)
The study has other limitations, which must
be considered when appraising its results. First
of all, regarding the representativeness of the
sample, it has to be mentioned, that at the
present time, no data are available regarding the
prevalence of AD in the Marche Region and the
characteristics of the population of caregivers. This
is a major issue for the Regional Government,
which the UP-TECH project is actually trying to
address. However, the 67% recruitment response
rate achieved on the lists of the AEU patients
(which include all patients of the Region with
a diagnosis of AD) and the large size of the
sample (n = 438 patient–caregiver dyads), make us
optimistic regarding the latter’s representativeness
of Marche’s population of patients with moderate
AD, living in the community, with at least one
family caregiver. The characteristics of the UP-
TECH sample are indeed consistent with those of
the samples enrolled by other studies (both RCTs
and cross-sectional studies) targeting patients with
dementia (Coon et al., 2003; Sink et al., 2006;
Black et al., 2013) and those with moderate AD
(Wisniewski et al., 2003; Belle et al., 2006). In these
studies, the caregivers had a very similar age and
gender composition, while the dementia patients
had a comparable profile in terms of age, gender,
MMSE score, and ADL and IADL dependency.
A second potential limitation of the paper refers
to the inclusion criteria of our study population,
i.e., patients with moderate AD, with at least one
family caregiver. This implies that those patients
without a family caregiver – although their number
should be relatively small in the Italian population –
were not included in the analysis. A third limitation
relates to the lack of conventional measures of AD
symptom gravity, such as the NPI (Cummings,
1997) and the Behave-AD (Reisberg et al., 1996), in
the UP-TECH study. However, we tried to address
this by using the caregivers’ reports of behavioral
disturbances, which is a very common proxy in the
health economic analysis of AD cost (Jonsson and
Wimo, 2009). Last but not least, for some cost
items, we could not use the actual price, but had to
rely on an estimate from either surveys or the cost
of labor set by the national employment contracts.
Even with these limitations, our up-to-date study is
one of the most realistic carried out in Italy, as it is
based on a comprehensive and reliable collection
of data, following an intensive training of nurse
assessors and a continuous monitoring of a large
number of patients.
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